Biopharmaceutical Analysis & Statistics, November 2014 (p3)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

All regions

You might be interested in: Protein, Biomedical, Antibody, more »

61-100 of about 900 reports

Purchase Reports From Reputable Market Research Publishers

BC Biomedical Laboratories Ltd. SWOT Analysis, Strategy, Revenues and Profits

BC Biomedical Laboratories Ltd. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : Canada, United Kingdom
biOasis Technologies Inc. (Symbol:BTI) SWOT Analysis, Strategy, Revenues and Profits

biOasis Technologies Inc. (Symbol:BTI) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States, Canada, United Kingdom
BioMedical Enterprises, Inc. SWOT Analysis, Strategy, Revenues and Profits

BioMedical Enterprises, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Biomm S.A. (Symbol:BIOM4) SWOT Analysis, Strategy, Revenues and Profits

Biomm S.A. (Symbol:BIOM4) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
BioTransplant Inc. SWOT Analysis, Strategy, Revenues and Profits

BioTransplant Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Calypte Biomedical Corporation (Symbol:CBMC) SWOT Analysis, Strategy, Revenues and Profits

Calypte Biomedical Corporation (Symbol:CBMC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Entest BioMedical Inc. (Symbol:ENTB) SWOT Analysis, Strategy, Revenues and Profits

Entest BioMedical Inc. (Symbol:ENTB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Exploit Technologies Pte Ltd SWOT Analysis, Strategy, Revenues and Profits

Exploit Technologies Pte Ltd SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : Singapore
IBEX Technologies Inc. (Symbol:IBT) SWOT Analysis, Strategy, Revenues and Profits

IBEX Technologies Inc. (Symbol:IBT) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : Canada
ImmunoVaccine Technologies Inc. (Symbol:IMV) SWOT Analysis, Strategy, Revenues and Profits

ImmunoVaccine Technologies Inc. (Symbol:IMV) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
Immuron Limited (Symbol:IMC) SWOT Analysis, Strategy, Revenues and Profits

Immuron Limited (Symbol:IMC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : Australia, South Africa, Canada, World
Innate Pharma SA (Symbol:IPH) SWOT Analysis, Strategy, Revenues and Profits

Innate Pharma SA (Symbol:IPH) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
ISU ABXIS Co.,Ltd. (Symbol:086890) SWOT Analysis, Strategy, Revenues and Profits

ISU ABXIS Co.,Ltd. (Symbol:086890) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : South Korea
MP Biomedicals, LLC SWOT Analysis, Strategy, Revenues and Profits

MP Biomedicals, LLC SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Nova Biomedical Corporation SWOT Analysis, Strategy, Revenues and Profits

Nova Biomedical Corporation SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Omeros Corporation (Symbol:OMER) SWOT Analysis, Strategy, Revenues and Profits

Omeros Corporation (Symbol:OMER) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Omnimmune Holdings, Inc. (Symbol:OMMH) SWOT Analysis, Strategy, Revenues and Profits

Omnimmune Holdings, Inc. (Symbol:OMMH) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Pall Biomedical Inc SWOT Analysis, Strategy, Revenues and Profits

Pall Biomedical Inc SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Peregrine Pharmaceuticals, Inc. (Symbol:PPHM) SWOT Analysis, Strategy, Revenues and Profits

Peregrine Pharmaceuticals, Inc. (Symbol:PPHM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
PharmAthene, Inc. (Symbol:PIP) SWOT Analysis, Strategy, Revenues and Profits

PharmAthene, Inc. (Symbol:PIP) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Procognia Limited (Symbol:PRCG) SWOT Analysis, Strategy, Revenues and Profits

Procognia Limited (Symbol:PRCG) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : Israel
ProMetic Life Sciences Inc. (Symbol:PLI) SWOT Analysis, Strategy, Revenues and Profits

ProMetic Life Sciences Inc. (Symbol:PLI) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : Canada
Protalex, Inc. (Symbol:PRTX) SWOT Analysis, Strategy, Revenues and Profits

Protalex, Inc. (Symbol:PRTX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States, South Africa
QuantRx Biomedical Corporation (Symbol:QTXB) SWOT Analysis, Strategy, Revenues and Profits

QuantRx Biomedical Corporation (Symbol:QTXB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Verenium Corporation (Symbol:VRNM) SWOT Analysis, Strategy, Revenues and Profits

Verenium Corporation (Symbol:VRNM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Kamada Ltd. (Symbol:KMDA) SWOT Analysis, Strategy, Revenues and Profits

Kamada Ltd. (Symbol:KMDA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
iBio, Inc. (IBIO) - Financial and Strategic SWOT Analysis Review

iBio, Inc. (IBIO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary iBio, Inc. (iBio) is a biotechnology company. The company develops and offers pharmaceutical product applications. It offers products such as vaccines, and biotherapeutics. iBio offers vaccines ...

  • Industries : Biopharmaceutical
  • Countries : United States
Medgenics Inc. (Symbol:MEDG) SWOT Analysis, Strategy, Revenues and Profits

Medgenics Inc. (Symbol:MEDG) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Medicago Inc. (Symbol:MDG) SWOT Analysis, Strategy, Revenues and Profits

Medicago Inc. (Symbol:MDG) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : Canada
Shin Nippon Biomedical Laboratories, Ltd. (Symbol:2395) SWOT Analysis, Strategy, Revenues and Profits

Shin Nippon Biomedical Laboratories, Ltd. (Symbol:2395) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States

28 Companies

Read our Company Profiles

Johnson and Johnson

United States

Biogen Idec

United States

GlaxoSmithKline P.L.C.

United States

Abbott Laboratories

United States

Amgen Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.